Sign In
12 May 2009 07:00
ο»Ώ
Ark Therapeutics Group plc
12 May 2009
Β
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
Β
1.Β Name of theΒ issuer
Ark Therapeutics Group PLC
Β
2.Β State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006).
(i)
Β
3.Β Name ofΒ person discharging managerial responsibilities/director
Andrew Christie
Β
4.Β State whether notification relates to aΒ personΒ connected with aΒ person discharging managerial responsibilities/directorΒ named in 3 and identify theΒ connected person
N/A
Β
5.Β Indicate whether the notification is in respect of a holding of theΒ personΒ referred to in 3 or 4 above or in respect of a non-beneficial interest
Beneficial holding of the person indicated in 3 above
Β
6.Β Description ofΒ sharesΒ (includingΒ class), debentures or derivatives or financial instruments relating toΒ shares
1 pence ordinary shares
Β
7. Name of registered shareholders(s) and, if more than one, the number ofΒ sharesΒ held by each of them
Andrew Christie
Β
8Β State the nature of the transaction
Purchase of shares
Β
9. Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ acquired
13,207Β
Β
10.Β Percentage of issuedΒ classΒ acquired (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)
0.006%
Β
11.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ disposed
N/A
Β
12.Β Percentage of issuedΒ classΒ disposed (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)Β
N/A
Β
13.Β Price perΒ shareΒ or value of transaction
52.5 pence
Β
14.Β Date and place of transaction
11 May 2009,Β UK
Β
15.Β Total holding following notification and total percentage holding following notification (anyΒ treasury sharesΒ should not be taken into account when calculating percentage)
25,865Β Β (0.012%)
Β
16.Β Date issuer informed of transaction
11 May 2009
Β
17.Β Any additional information
N/A
18.Β Name of contact and telephone number for queries
Martyn Williams 020 7388 7722
Β
Name of authorised official ofΒ issuerΒ responsible for making notification
Martyn Williams
Company Secretary
Date of notification
12 May 2009
Follow the stocks
